Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9655918
SERIAL NO

14389301

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FIDIA FARMACEUTICI S P AVIA PONTE DELLA FABBRICA 3/A ABANO TERME (PD) 35031

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Campisi, Monica Abano Terme, IT 9 2
Carpanese, Giancarlo Abano Terme, IT 3 1
Corsa, Vincenza Abano Terme, IT 9 3
Zanellato, Anna Maria Abano Terme, IT 16 92

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 23, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00